These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16081627)

  • 1. Dose response to rhCC10-augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: physiological, inflammatory, and kinetic profiles.
    Shashikant BN; Miller TL; Welch RW; Pilon AL; Shaffer TH; Wolfson MR
    J Appl Physiol (1985); 2005 Dec; 99(6):2204-11. PubMed ID: 16081627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human Clara cell secretory protein treatment increases lung mRNA expression of surfactant proteins and vascular endothelial growth factor in a premature lamb model of respiratory distress syndrome.
    Wolfson MR; Funanage VL; Kirwin SM; Pilon AL; Shashikant BN; Miller TL; Shaffer TH
    Am J Perinatol; 2008 Nov; 25(10):637-45. PubMed ID: 18841530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant Clara cell secretory protein (rhCC10) on inflammatory-related matrix metalloproteinase activity in a preterm lamb model of neonatal respiratory distress.
    Miller TL; Shashikant BN; Pilon AL; Pierce RA; Shaffer TH; Wolfson MR
    Pediatr Crit Care Med; 2007 Jan; 8(1):40-6. PubMed ID: 17149150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Osborn DA
    Cochrane Database Syst Rev; 2011 May; 2011(5):CD008308. PubMed ID: 21563168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety, pharmacokinetics, and anti-inflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome.
    Levine CR; Gewolb IH; Allen K; Welch RW; Melby JM; Pollack S; Shaffer T; Pilon AL; Davis JM
    Pediatr Res; 2005 Jul; 58(1):15-21. PubMed ID: 15774846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of intratracheal recombinant human Clara cell protein in a newborn piglet model of acute lung injury.
    Chandra S; Davis JM; Drexler S; Kowalewska J; Chester D; Koo HC; Pollack S; Welch R; Pilon A; Levine CR
    Pediatr Res; 2003 Oct; 54(4):509-15. PubMed ID: 12815115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CC10 reduces inflammation in meconium aspiration syndrome in newborn piglets.
    Angert RM; Pilon AL; Chester D; Davis JM
    Pediatr Res; 2007 Dec; 62(6):684-8. PubMed ID: 17957145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an intratracheally delivered anti-inflammatory protein (rhCC10) on physiological and lung structural indices in a juvenile model of acute lung injury.
    Miller TL; Shashikant BN; Pilon AL; Pierce RA; Shaffer TH; Wolfson MR
    Biol Neonate; 2006; 89(3):159-70. PubMed ID: 16210850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human Clara cell secretory protein in acute lung injury of the rabbit: effect of route of administration.
    Miller TL; Shashikant BN; Melby JM; Pilon AL; Shaffer TH; Wolfson MR
    Pediatr Crit Care Med; 2005 Nov; 6(6):698-706. PubMed ID: 16276338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratracheal atomized surfactant provides similar outcomes as bolus surfactant in preterm lambs with respiratory distress syndrome.
    Milesi I; Tingay DG; Zannin E; Bianco F; Tagliabue P; Mosca F; Lavizzari A; Ventura ML; Zonneveld CE; Perkins EJ; Black D; Sourial M; Dellacá RL
    Pediatr Res; 2016 Jul; 80(1):92-100. PubMed ID: 26954481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurity.
    Davis JM; Pilon AL; Shenberger J; Breeze JL; Terrin N; Mazela J; Gulczynska E; Lauterbach R; Parad R
    Pediatr Res; 2019 Aug; 86(2):254-260. PubMed ID: 31086287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral and lung effects of a new generation synthetic surfactant with SP-B and SP-C analogs in preterm lambs.
    Rey-Santano C; Mielgo VE; Murgia X; Gomez-Solaetxe MA; Salomone F; Bianco F; Pelizzi N; Loureiro B; López de Heredia Y Goya J
    Pediatr Pulmonol; 2017 Jul; 52(7):929-938. PubMed ID: 28221717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant.
    van Zyl JM; Smith J
    Drug Des Devel Ther; 2013; 7():905-16. PubMed ID: 24039400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and sustained effects of aerosolized vs. bolus surfactant therapy in premature lambs with respiratory distress syndrome.
    Rey-Santano C; Mielgo VE; Andres L; Ruiz-del-Yerro E; Valls-i-Soler A; Murgia X
    Pediatr Res; 2013 May; 73(5):639-46. PubMed ID: 23403804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome.
    Köksal N; Akpinar R; Cetinkaya M
    Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulization of Poractant alfa via a vibrating membrane nebulizer in spontaneously breathing preterm lambs with binasal continuous positive pressure ventilation.
    Hütten MC; Kuypers E; Ophelders DR; Nikiforou M; Jellema RK; Niemarkt HJ; Fuchs C; Tservistas M; Razetti R; Bianco F; Kramer BW
    Pediatr Res; 2015 Dec; 78(6):664-9. PubMed ID: 26322413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin A is systemically bioavailable after intratracheal administration with surfactant in an animal model of newborn respiratory distress.
    Singh AJ; Bronshtein V; Khashu M; Lee K; Potts JE; Friel J; Chessex P
    Pediatr Res; 2010 Jun; 67(6):619-23. PubMed ID: 20216104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of poractant alfa and lyophilized lucinactant in a preterm lamb model of acute respiratory distress.
    Mazela J; Merritt A; Terry MH; Gregory TJ; Blood AB
    Pediatr Res; 2012 Jul; 72(1):32-7. PubMed ID: 22465908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS.
    Wolfson MR; Wu J; Hubert TL; Gregory TJ; Mazela J; Shaffer TH
    Pediatr Res; 2012 Oct; 72(4):375-83. PubMed ID: 22821059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and sustained effects of lucinactant versus poractant-alpha on pulmonary gas exchange and mechanics in premature lambs with respiratory distress syndrome.
    Gastiasoro-Cuesta E; Alvarez-Diaz FJ; Rey-Santano C; Arnaiz-Renedo A; Loureiro-Gonzalez B; Valls-i-Soler A
    Pediatrics; 2006 Feb; 117(2):295-303. PubMed ID: 16452346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.